Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4539546
Max Phase: Preclinical
Molecular Formula: C13H12N2O
Molecular Weight: 212.25
Molecule Type: Unknown
Associated Items:
ID: ALA4539546
Max Phase: Preclinical
Molecular Formula: C13H12N2O
Molecular Weight: 212.25
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)Nc2ccncc2)cc1
Standard InChI: InChI=1S/C13H12N2O/c1-10-2-4-11(5-3-10)13(16)15-12-6-8-14-9-7-12/h2-9H,1H3,(H,14,15,16)
Standard InChI Key: GCFLVEVTCIKTNM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 212.25 | Molecular Weight (Monoisotopic): 212.0950 | AlogP: 2.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 41.99 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.62 | CX LogP: 2.36 | CX LogD: 2.35 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.83 | Np Likeness Score: -1.66 |
1. Wicht KJ, Combrinck JM, Smith PJ, Hunter R, Egan TJ.. (2016) Identification and SAR Evaluation of Hemozoin-Inhibiting Benzamides Active against Plasmodium falciparum., 59 (13): [PMID:27299916] [10.1021/acs.jmedchem.6b00719] |
Source(1):